Degnan Chris Insider Trades

Insider Trading History

Track insider trading activity for Degnan Chris. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
UroGen Pharma
UroGen Pharma URGN
Chief Financial Officer
Holding Value $900k 32,609 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$639k 32,609 shares
$19.61
$27.60
UroGen Pharma
UroGen Pharma URGN
Chief Financial Officer
Holding Value $247k 8,967 shares
Last Trade
Oct 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$77.7k 4,483 shares
$17.33
$27.60
UroGen Pharma
UroGen Pharma URGN
Chief Financial Officer
Holding Value $124k 4,483 shares
Last Trade
Oct 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$77.7k 4,483 shares
$17.33
$27.60
UroGen Pharma
UroGen Pharma URGN
Chief Financial Officer
Holding Value $62.9k 2,280 shares
Last Trade
Oct 08, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$37.1k 2,203 shares
$16.85
$27.60
UroGen Pharma
UroGen Pharma URGN
Chief Financial Officer
Holding Value $2.05M 74,142 shares
Last Trade
Oct 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$972k 74,142 shares
$13.11
$27.60
Galera Therapeutics
Galera Therapeutics GRTX
Chief Financial Officer
Holding Value $1k 10,000 shares
Last Trade
Mar 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.6k 10,000 shares
$1.96
$0.10
Galera Therapeutics
Galera Therapeutics GRTX
Chief Financial Officer
Holding Value $18.5k 185,000 shares
Last Trade
Feb 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$329k 185,000 shares
$1.78
$0.10
Galera Therapeutics
Galera Therapeutics GRTX
Chief Financial Officer
Holding Value $13.5k 135,000 shares
Last Trade
Feb 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$302k 135,000 shares
$2.24
$0.10
Galera Therapeutics
Galera Therapeutics GRTX
Chief Financial Officer
Holding Value $8.25k 82,500 shares
Last Trade
Jan 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$989k 82,500 shares
$11.99
$0.10
Galera Therapeutics
Galera Therapeutics GRTX
Chief Financial Officer
Holding Value $7.44k 74,435 shares
Last Trade
Jan 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.1M 74,435 shares
$14.84
$0.10
Galera Therapeutics
Galera Therapeutics GRTX
Chief Financial Officer
Holding Value $23k 229,513 shares
Last Trade
Nov 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.10
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Chief Financial Officer
Holding Value $271k 44,000 shares
Last Trade
Feb 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$498k 44,000 shares
$11.32
$6.15
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Chief Financial Officer
Holding Value $18.5k 3,000 shares
Last Trade
Jun 19, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$58.7k 3,000 shares
$19.57
$6.15
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 14, 2018 Sale
No data
No data
$6.15

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up